Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13.

Abstract

HIV infection in the combination antiretroviral therapy (cART) era has become a chronic disease with a life expectancy almost identical to those free from this infection. Concomitantly, chronic diseases such as neurodegenerative diseases have emerged as serious clinical problems. HIV-induced cognitive changes, although clinically very diverse are collectively called HIV-associated neurocognitive disorder (HAND). HAND, which until the introduction of cART manifested clinically as a subcortical disorder, is now considered primarily cognitive disorder, which makes it similar to diseases like Alzheimer's (AD) and Parkinson's disease (PD). The pathogenesis involves either the direct effects of the virus or the effect of viral proteins such as Tat, Ggp120, and Nef. These proteins are either capable of destroying neurons directly by inducing neurotoxic mediators or by initiating neuroinflammation by microglia and astrocytes. Recently, it has become recognized that HIV infection is associated with increased production of the beta-amyloid peptide (Aβ) which is a characteristic of AD. Moreover, amyloid plaques have also been demonstrated in the brains of patients suffering from HAND. Thus, the question arises whether this production of Aβ indicates that HAND may lead to AD or it is a form of AD or this increase in Aβ production is only a bystander effect. It has also been discovered that APP in HIV and its metabolic product Aβ in AD manifest antiviral innate immune peptide characteristics. This review attempts to bring together studies linking amyloid precursor protein (APP) and Aβ production in HIV infection and their possible impact on the course of HAND and AD. These data indicate that human defense mechanisms in HAND and AD are trying to contain microorganisms by antimicrobial peptides, however by employing different means. Future studies will, no doubt, uncover the relationship between HAND and AD and, hopefully, reveal novel treatment possibilities.

Keywords: Alzheimer’s disease; Amyloid beta peptide; Amyloid precursor protein; Antimicrobial peptide; Exosomes; HAND; HIV Tat; HIV infection; Retroviruses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS Dementia Complex / etiology
  • AIDS Dementia Complex / metabolism
  • AIDS Dementia Complex / pathology
  • Aged
  • Alzheimer Disease / etiology*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / biosynthesis*
  • Amyloid beta-Peptides / physiology
  • Anti-HIV Agents / therapeutic use
  • Apoptosis
  • Astrocytes / virology
  • Bacterial Infections / complications
  • Brain / metabolism*
  • Brain / pathology
  • Brain / virology
  • Cytokines / metabolism*
  • Endogenous Retroviruses / pathogenicity
  • Endogenous Retroviruses / physiology
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • HIV Infections / psychology
  • HIV-1 / physiology
  • Human Immunodeficiency Virus Proteins / physiology*
  • Humans
  • Hydrogen-Ion Concentration
  • Lymphocytes / virology
  • Lysosomes / chemistry
  • Microglia / virology
  • Models, Neurological
  • Neurocognitive Disorders / etiology
  • Neurocognitive Disorders / metabolism
  • Neurocognitive Disorders / pathology
  • Neurons / metabolism
  • Neurons / pathology
  • Plaque, Amyloid
  • Virus Activation
  • Virus Diseases / complications

Substances

  • Amyloid beta-Peptides
  • Anti-HIV Agents
  • Cytokines
  • Human Immunodeficiency Virus Proteins

Grants and funding